AstraZeneca must prove it won't profit from COVID-19 vaccine - MSF

FILE PHOTO: A test tube labeled with the vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/File Photo/File Photo

BRUSSELS (Reuters) - AstraZeneca must provide reassurance that it will not profit from its potential COVID-19 vaccine, non-governmental organisation Medecins Sans Frontieres (MSF) said on Tuesday, urging the company to make public its supply contracts.

The British firm said on Monday its COVID-19 vaccine was 70% effective in pivotal trials and could be up to 90% effective, giving the world's fight against the global pandemic a third new weapon that can be cheaper to make, easier to distribute and faster to scale-up than rivals.